Ergotamine abuse and extra-hepatic portal hypertension
- PMID: 4022885
- PMCID: PMC2418255
- DOI: 10.1136/pgmj.61.715.461
Ergotamine abuse and extra-hepatic portal hypertension
Abstract
Arterial complications following ergotamine therapy have been well recognized since the beginning of this century. Venous complications, however, have only rarely been reported. A 48 year old Nigerian woman developed extra-hepatic portal hypertension coincident with a chronic overdosage of ergotamine. The literature elucidating the possible mechanisms involved is reviewed.
Similar articles
-
[Headache caused by analgesic and/or ergotamine abuse].Clin Ter. 1991 May 15;137(3):169-83. Clin Ter. 1991. PMID: 1831085 Review. Italian.
-
Establishment of a hepatic cirrhosis and portal hypertension model by hepatic arterial perfusion with 80% alcohol.World J Gastroenterol. 2015 Aug 28;21(32):9544-53. doi: 10.3748/wjg.v21.i32.9544. World J Gastroenterol. 2015. PMID: 26327762 Free PMC article.
-
Carotid artery dissection in ergotamine abuse.Headache. 2004 Oct;44(9):930-2. doi: 10.1111/j.1526-4610.2004.04178_3.x. Headache. 2004. PMID: 15447707
-
Reduced serotonin vascular sensitivity in ergotamine abusers.Cephalalgia. 1989 Dec;9(4):259-64. doi: 10.1046/j.1468-2982.1989.0904259.x. Cephalalgia. 1989. PMID: 2611883
-
[Methotrexate, liver and rheumatoid arthritis in tropical areas].Sante. 2001 Jul-Sep;11(3):195-200. Sante. 2001. PMID: 11641084 Review. French.
Cited by
-
Evidence of Misclassification of Drug-Event Associations Classified as Gold Standard 'Negative Controls' by the Observational Medical Outcomes Partnership (OMOP).Drug Saf. 2016 May;39(5):421-32. doi: 10.1007/s40264-016-0392-2. Drug Saf. 2016. PMID: 26879560